Cargando…
Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Clinical Oncology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541452/ https://www.ncbi.nlm.nih.gov/pubmed/31157314 http://dx.doi.org/10.1200/PO.19.00011 |
| _version_ | 1783422776164483072 |
|---|---|
| author | Suzawa, Ken Offin, Michael Schoenfeld, Adam J. Plodkowski, Andrew J. Odintsov, Igor Lu, Daniel Lockwood, William W. Arcila, Maria E. Rudin, Charles M. Drilon, Alexander Yu, Helena A. Riely, Gregory J. Somwar, Romel Ladanyi, Marc |
| author_facet | Suzawa, Ken Offin, Michael Schoenfeld, Adam J. Plodkowski, Andrew J. Odintsov, Igor Lu, Daniel Lockwood, William W. Arcila, Maria E. Rudin, Charles M. Drilon, Alexander Yu, Helena A. Riely, Gregory J. Somwar, Romel Ladanyi, Marc |
| author_sort | Suzawa, Ken |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6541452 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | American Society of Clinical Oncology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65414522019-05-29 Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer Suzawa, Ken Offin, Michael Schoenfeld, Adam J. Plodkowski, Andrew J. Odintsov, Igor Lu, Daniel Lockwood, William W. Arcila, Maria E. Rudin, Charles M. Drilon, Alexander Yu, Helena A. Riely, Gregory J. Somwar, Romel Ladanyi, Marc JCO Precis Oncol Case Report American Society of Clinical Oncology 2019-05-10 /pmc/articles/PMC6541452/ /pubmed/31157314 http://dx.doi.org/10.1200/PO.19.00011 Text en © 2019 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License |
| spellingShingle | Case Report Suzawa, Ken Offin, Michael Schoenfeld, Adam J. Plodkowski, Andrew J. Odintsov, Igor Lu, Daniel Lockwood, William W. Arcila, Maria E. Rudin, Charles M. Drilon, Alexander Yu, Helena A. Riely, Gregory J. Somwar, Romel Ladanyi, Marc Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer |
| title | Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer |
| title_full | Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer |
| title_fullStr | Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer |
| title_full_unstemmed | Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer |
| title_short | Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer |
| title_sort | acquired met exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in egfr-mutated lung cancer |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541452/ https://www.ncbi.nlm.nih.gov/pubmed/31157314 http://dx.doi.org/10.1200/PO.19.00011 |
| work_keys_str_mv | AT suzawaken acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer AT offinmichael acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer AT schoenfeldadamj acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer AT plodkowskiandrewj acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer AT odintsovigor acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer AT ludaniel acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer AT lockwoodwilliamw acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer AT arcilamariae acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer AT rudincharlesm acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer AT drilonalexander acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer AT yuhelenaa acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer AT rielygregoryj acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer AT somwarromel acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer AT ladanyimarc acquiredmetexon14alterationdrivessecondaryresistancetoepidermalgrowthfactorreceptortyrosinekinaseinhibitorinegfrmutatedlungcancer |